Efficacy of Twice a Day Bismuth Quadruple Therapy for Second-Line Treatment of <i>Helicobacter pylori</i> Infection
Bismuth quadruple therapy (BQT) is an effective treatment for <i>Helicobacter pylori</i> infection. However, frequent dosing schedules of BQT regimen often compromise drug adherence and may affect treatment outcomes. This retrospective study aimed to investigate the efficacy of twice-dai...
Main Authors: | Jeemyoung Kim, Eun Jeong Gong, Myeongsook Seo, Hyun Il Seo, Jong Kyu Park, Sang Jin Lee, Koon Hee Han, Woo Jin Jeong, Young Don Kim, Gab Jin Cheon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/1/56 |
Similar Items
-
Seven Days of Bismuth-Based Quadruple Therapy Is as Effective for the First-Line Treatment of Clarithromycin-Resistant Confirmed <i>Helicobacter pylori</i> Infection as 14 Days of Bismuth-Based Quadruple Therapy
by: Sang-Gon Moon, et al.
Published: (2022-07-01) -
Minocycline/Amoxicillin-Based Bismuth Quadruple Therapy for <i>Helicobacter pylori</i> Eradication: A Pilot Study
by: Senlin You, et al.
Published: (2024-02-01) -
The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication
by: Soohoon Kwon, et al.
Published: (2018-04-01) -
Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of <i>Helicobacter pylori</i>
by: Hasan Salman, et al.
Published: (2010-01-01) -
Second-Line Bismuth-Containing Quadruple Therapy for <i>Helicobacter</i><i>pylori</i> Infection: A 12-Year Study of Annual Eradication Rates
by: Kiwon Shin, et al.
Published: (2021-07-01)